TrialPloS one2011

Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy.

Maria Vinaixa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.